Dec 21, 2023
Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease whose management is complex and requires open communication amongst a multidisciplinary care team. It has a high rate of relapse, with up to 40 percent of patients relapsing within the first two years after primary treatment. Management of a patient with...
Dec 14, 2023
As the use of chimeric antigen receptor (CAR) T-cell therapy continues to expand as an effective treatment for hematologic malignancies, understanding how to identify eligible patients early and implementation of an effective framework for identification can improve care coordination and better prepare community cancer...
Nov 16, 2023
The aging US population is predicted to drive an increase in cancer incidence of almost 50% by 2050. At the same time, some cancer programs face capacity and resource constraints—which will continue to increase as demand for cancer services rises. Many cancer programs are also facing significant challenges with...
Nov 9, 2023
Health technology performance and integration of electronic health record (EHR) systems—the creation of interfaces between EHRs and reference labs performing biomarker testing— have become critical factors in conducting efficient and equitable biomarker testing at cancer programs nationwide. At ACCC’s 40th...
Oct 19, 2023
In 2020, this community-based cancer program started laying the foundation for a disease-site specific oncology patient navigation program that would grow exponentially over the next 2 years. In addition to a rapidly growing patient caseload, nurse navigator responsibilities grew extensively, largely due to increasing...